HCC in the Setting of Hepatitis B: Key Issues for Clinicians Providing Care for Liver Diseases

Download All
Watch 3 expert faculty in the multimedia module to learn about HCC risk assessment, screening, and surveillance in the setting of hepatitis B. Consolidate your learning with the expert-authored Clinical Focus, faculty ClinicalThought commentaries, and the companion Quick Reference Guide. Share the downloadable slides with your colleagues.
person default
Yasuhito Tanaka, MD, PhD
Norah Terrault Headshot
Norah Terrault, MD, MPH
Grace LH Wong, 医学博士
Grace LH Wong, MD

ClinicalThought

亚太地区在评估 HBV 患者的 HCC 风险和跨学科管理方面的注意事项

Grace LH Wong, 医学博士 Released: April 16, 2021

Asia-Pacific considerations in assessing HCC risk in patients with HBV and interdisciplinary management of HCC.

Grace LH Wong, MD Released: April 15, 2021

Patients achieving a functional cure for chronic hepatitis B with nucleos(t)ide analogue treatment may still develop HCC. What tools do we have to predict which patients will experience progression of liver disease?

person default Yasuhito Tanaka, MD, PhD Released: May 6, 2021

ヌクレオチ(シ)ド類似物治療によって慢性B型肝炎の機能的治癒を達成している患者さんでも、HCCが発生する可能性があります。患者さんが肝臓疾患の進行を経験するかを予測するためには、どのようなツールがあるでしょうか?

person default Yasuhito Tanaka, MD, PhD Released: May 11, 2021

HCC risk scores can inform a personalized approach to HCC surveillance in patients with chronic hepatitis B by allowing patients at very low risk to avoid burdensome surveillance and identifying high-risk patients who may benefit from intensive surveillance

Norah Terrault Headshot Norah Terrault, MD, MPH Released: June 4, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue